November 11, 2021
Fitch, Even, Tabin & Flannery is pleased to announce that Irfan Hassam-Malani and Prestin Van Mieghem have joined the firm’s Chicago office as associates.
A registered patent attorney, Irfan Hassam-Malani assists clients with patent preparation and prosecution, IP litigation, product clearance, legal opinions, and global intellectual property portfolio management and transactions. He has worked with large global manufacturers in the consumer electronics, telecommunications, chemicals/chemical engineering, and food/agricultural sciences industries. Irfan had previously worked with Fitch Even as a law clerk. He graduated cum laude from the University of Illinois College of Law in May 2021 and earned a B.S. degree in Chemistry and a B.A.L.A.S. degree in Economics from the University of Illinois in 2018.
Prestin Van Mieghem focuses his practice on patent preparation and prosecution, freedom-to-operate, infringement analysis, and global portfolio prosecution. As a law clerk with Fitch Even, Prestin worked with clients innovating in areas including mechanical engineering and other high-tech industries. He has drafted and reviewed a variety of business contracts and intellectual property agreements, including product distribution agreements, licensing agreements, and joint development agreements. He earned his J.D. from Chicago-Kent College of Law, graduating cum laude in May 2021. He received a B.S. degree in Physics, summa cum laude, from Illinois State University in 2018.
We are delighted to welcome Irfan and Prestin to the Fitch Even team!
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more